The company
InspireMD Inc.
NSPR · Nasdaq
NSPR stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 51.4% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $977K
- Insider sales, 12 months
- $254K
- Officials’ trades on record
- 0
- Institutions holding
- 33 (+0)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Paul StukaDirector | bought | 20,000at $0.875 | 27 May 2026filed 29 May 2026 |
| Shane Thomas GleasonChief Commercial Officer | sold | 22,778at $1.01 | 19 May 2026filed 21 May 2026 |
| Paul StukaDirector | bought | 5,000at $1.15 | 14 May 2026filed 15 May 2026 |
| Paul StukaDirector | bought | 10,000at $1.16 | 13 May 2026filed 15 May 2026 |
| Marvin SlosmanCEO and President | bought | 21,000at $1.20 | 12 May 2026filed 13 May 2026 |
| Paul StukaDirector | bought | 10,000at $1.19 | 11 May 2026filed 12 May 2026 |
| Paul StukaDirector | bought | 10,000at $1.19 | 11 May 2026filed 13 May 2026 |
| Paul StukaDirector | bought | 65,626at $1.16 | 8 May 2026filed 12 May 2026 |
| Paul StukaDirector | bought | 65,626at $1.16 | 8 May 2026filed 13 May 2026 |
| Gary S. RoubinDirector | bought | 90,000at $1.18 | 7 May 2026filed 8 May 2026 |
| Paul StukaDirector | bought | 6,378at $1.15 | 7 May 2026filed 8 May 2026 |
| Scott R. WardDirector | bought | 73,255at $1.15 | 7 May 2026filed 8 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Rosalind Advisors, Inc.unchanged · filed 14 Aug 2026 | 3,905,743$2.7M | 00.0% |
| Aberdeen Group plcadded · filed 31 Jul 2026 | 3,698,364$2.6M | +525,000+16.5% |
| Nantahala Capital Management, LLCunchanged · filed 14 Aug 2026 | 3,376,484$2.4M | 00.0% |
| ORBIMED ADVISORS LLCunchanged · filed 14 Aug 2026 | 3,133,405$2.2M | 00.0% |
| Parkman Healthcare Partners LLCunchanged · filed 14 Aug 2026 | 2,416,518$1.7M | 00.0% |
| MARSHALL WACE, LLPunchanged · filed 13 Aug 2026 | 1,860,405$1.3M | 00.0% |
| Soleus Capital Management, L.P.unchanged · filed 11 Aug 2026 | 1,045,708$732K | 00.0% |
| PURA VIDA INVESTMENTS, LLCunchanged · filed 13 Aug 2026 | 450,517$315K | 00.0% |
| Affiance Financial, LLCunchanged · filed 9 Jul 2026 | 250,370$175K | 00.0% |
| Velan Capital Investment Management LPreduced · filed 14 Aug 2026 | 148,138$104K | -1,951,514−92.9% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.